Last edition
News about Biotechnology
South Africa pushes for local manufacturing of Gilead's HIV prevention drug
Gilead Sciences’ long-acting HIV prevention drug, lenacapavir, could soon be produced in South Africa as the government pushes to expand regional manufacturing and improve access to the therapy.
Biotechnology | 05/03/2026 | By Darshana | 172
YD Bio USA to Serve as Exclusive US Agent for YC Biotech's FDA Submissions
YD Bio Limited has announced that its subsidiary, YD Bio USA, Inc., has entered into a master strategic alliance agreement with YC Biotech Co Ltd to establish a cross-border regulatory platform focused on US Food and Drug Administration (FDA) submissions.
Biotechnology | 01/03/2026 | By Darshana | 165
GSK's Linerixibat Granted Priority Review in China for Cholestatic Pruritus in PBC
China’s drug regulator has accepted GSK’s linerixibat for priority review to treat cholestatic pruritus in primary biliary cholangitis, supported by Phase III data showing significant and sustained itch relief.
Biotechnology | 27/02/2026 | By News Bureau | 278
Novo Nordisk Signs USD 2.1 Billion Pact with Vivtex to Develop Oral Obesity Therapies
Novo Nordisk has entered into a strategic collaboration with US-based Vivtex to develop next-generation oral biologic therapies for obesity, diabetes and related metabolic conditions.
Biotechnology | 27/02/2026 | By Darshana | 169
AS76 Brings Edge AI to Diagnostic Microscopy with On-Device High-Throughput Analysis
SigTuple has launched AS76, an AI-enabled digital morphology analyser designed to automate peripheral blood smear (PBS) microscopic review. The system integrates automated digital microscopy with on-device edge AI computing to deliver faster, standardized results while maintaining strict data privacy.
Biotechnology | 26/02/2026 | By Darshana | 161
IBA and Shreeji Sign Multi-Site Deal to Deploy Four Cyclotrons Across India
Ion Beam Applications S.A. (IBA), a global leader in particle accelerator technology and nuclear medicine solutions, has signed a multi-site agreement with Shreeji Imaging and Diagnostic Centre Pvt. Ltd. for the delivery and installation of four Cyclone KIUBE 300 cyclotrons in India.
Biotechnology | 21/02/2026 | By Darshana | 321
Newron Strengthens Clinical Development Funding with Multi-Tranche Share Deal
Newron Pharmaceuticals has secured a staged equity financing agreement worth up to EUR 38 million from a consortium of existing and new investors in Europe and Asia, strengthening its balance sheet as it advances late-stage clinical development of evenamide for treatment-resistant schizophrenia.
Biotechnology | 18/02/2026 | By Darshana | 215
Bio-Techne Corporation has received CE-IVD marking for its Ella benchtop immunoassay platform, enabling commercial availability across the European Union and opening new opportunities for clinical diagnostic use.
Biotechnology | 17/02/2026 | By Darshana | 165
Median Technologies, a France-based developer of artificial intelligence-powered software as a medical device, has entered a non-exclusive distribution agreement with Tempus AI, Inc. to commercialise its Eyonis LCS lung screening platform in the United States.
Biotechnology | 15/02/2026 | By Darshana | 327
THX Pharma and Biocodex Sign Licensing Deal for Rare Disease Drug Candidates
Biocodex secures global rights to Batten-1 and North American rights to TX01 from THX Pharma in a deal worth up to Euro 173 million to advance treatments for juvenile Batten disease, Gaucher disease and Niemann-Pick type C.
Biotechnology | 13/02/2026 | By News Bureau | 241
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy